U-Chart Analysis:Shionogi & Co.,Ltd.:4507

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Shionogi & Co.,Ltd. Go to web site 4507 Medicals 1st TSE March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Shionogi & Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Balance Sheet 2020年3月期 Shionogi & Co.,Ltd. Balance Sheet 2019年3月期 Shionogi & Co.,Ltd. Balance Sheet 2018年3月期 Shionogi & Co.,Ltd. Balance Sheet 2017年3月期 Shionogi & Co.,Ltd. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents 208,861 193,549 140,106 107,847 80,230
Other Current AssetsHelp 307,165 300,096 239,398 235,537 235,381
Tangible Fixed AssetsHelp 76,007 76,901 75,956 78,788 78,673
Intangible Fixed AssetHelp 46,536 47,804 42,208 49,970 26,283
Investments and OthersHelp 222,103 316,832 180,943 160,499 177,863
Total AssetsHelp 871,526 938,540 711,463 670,271 639,638
Total Current LiabilitiesHelp 102,175 129,766 91,598 117,480 99,772
Total Long-term LiabilitiesHelp 4,791 0 18,491 30,054 30,074
Shareholder's EquityHelp 764,560 808,774 601,374 522,737 509,792
Total LiabilitiesHelp 871,526 938,540 711,463 670,271 639,638

Shionogi & Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Profit and Loss Account 2020年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2019年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2018年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2017年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales 333,371 363,721 344,667 338,890 309,973
Total Sales 333,371 363,721 344,667 338,890 309,973
Cost of SalesHelp 56,782 55,591 73,911 77,777 74,758
Other Costs and RevenueHelp 154,396 175,371 161,890 177,234 168,529
Total CostsHelp 211,178 230,962 235,801 255,011 243,287
Net RevenueHelp 276,589 308,130 270,756 261,113 235,215
Earnings Before TaxHelp 158,516 174,043 137,378 122,695 97,452
Net IncomeHelp 122,193 132,759 108,866 83,879 66,686
Net Income 122,193 132,759 108,866 83,879 66,686

Shionogi & Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Cash Flow Statement 2020年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2019年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2018年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2017年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help 131,940 165,000 129,788 111,903 102,290
Investing Cash Flow(ICF)Help -29,144 -56,256 -51,238 -31,643 -32,894
Financing Cash FlowHelp -88,174 -89,912 -53,893 -57,411 -18,525
Exchange Difference of Cash and Cash EquivalentsHelp -1,560 832 -1,581 -1,268 -1,847
Net Increase and Decrease in Cash and Cash Equivalentsn 13,062 19,664 23,076 21,581 49,024

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Shionogi & Co.,Ltd.

Company where related level is highHelp

Sosei Group Corporation
Fuso Pharmaceutical Industries, Ltd.
Mochida Pharmaceutical Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
AnGes,Inc.
BrightPath Biotherapeutics Co., Ltd.
Takeda Pharmaceutical Company Limited
KYORIN Holdings,Inc.
Immuno-Biological Laboratories Co., Ltd.
D.Western Therapeutics Institute, Inc.